Agencourt Genomic Services Is Key Collaborator In Research Of Breast, Colon Cancers

Armen Hareyan's picture

Agencourt Bioscience Corporation's Genomic Services played an important role in a newly released study from Johns Hopkins Kimmel Cancer Center. The study follows a major report last year that announced the discovery of 200 genes linked to breast and colon cancers. This second report completes the study of the vast majority of protein-coding genes and catalogs the genetic changes that occur during

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.